Philadelphia Investment Partners »

Chemomab Therapeutics shares owned by Philadelphia Investment Partners

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Philadelphia Investment Partners from 13F filings

Historical chart of Philadelphia Investment Partners investment in Chemomab Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Philadelphia Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Philadelphia Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $13k 8.2k 1.57

More positions owned by Philadelphia Investment Partners

Vaneck Vectors Tr Fallen Angel Hg Etf (ANGL)
Palantir Technologies (PLTR)
Vaneck Vectors Tr Morningstar Wide Etf (MOAT)
Ishares Tr 3 7 Yr Treas Etf (IEI)
Ishares Tr Blackrock Etf (ICSH)
Spdr Series Trust Prtflo S&p500 Gw Etf (SPYG)
Ea Series Trust Freedom 100 Em (FRDM)
Dbx Tr Xtrak Msci Eafe Etf (DBEF)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Global Bd Etf (JPIB)
Apple (AAPL)
Vanguard Admiral Fds Inc Smllcp 600 Etf (VIOO)
Blackstone Group Inc Com Cl A (BX)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr Energy Etf (XLE)

View all positions for Philadelphia Investment Partners

Top funds holding Chemomab Therapeutics

ADAR1 Capital Management
Citadel Advisors
Kestra Private Wealth Services
Ikarian Capital
XTX Topco
Rhumbline Advisers
SmartHarvest Portfolios
Susquehanna International
Bnp Paribas Arbitrage, Snc
Philadelphia Investment Partners
GAMMA Investing
Morgan Stanley
SBI Securities
Caitong International Asset Management
UBS Group

View all funds holding Chemomab Therapeutics